MedTrace Logo

Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE

NCT03471234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 299

Last updated 2023-05-18

No results posted yet for this study

Summary

Prospective, multicenter, single arm registry to monitor post-market clinical outcomes of patients treated with Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer.

Conditions

Interventions

DEVICE

Angioplasty

Inspiron Drug Eluting stent implantation

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2020-10-30
Completion
2022-08-02

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471234 on ClinicalTrials.gov